Page last updated: 2024-11-02

pirenzepine and Shock

pirenzepine has been researched along with Shock in 1 studies

Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.

Shock: A pathological condition manifested by failure to perfuse or oxygenate vital organs.

Research Excerpts

ExcerptRelevanceReference
"day-1), carbamazepine, levomepromazine and alprazolan, a severe shock with bradycardia (HR: 40 b."3.70[Severe intoxication probably from olanzapine (Zyprexa). Beneficial effect of glucagon]. ( Joye, F; Marion, F; Michoux, I; Orrillard, M; Parisot, R, 1999)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Joye, F1
Orrillard, M1
Marion, F1
Michoux, I1
Parisot, R1

Other Studies

1 other study available for pirenzepine and Shock

ArticleYear
[Severe intoxication probably from olanzapine (Zyprexa). Beneficial effect of glucagon].
    Annales francaises d'anesthesie et de reanimation, 1999, Volume: 18, Issue:6

    Topics: Adult; Alprazolam; Antipsychotic Agents; Benzodiazepines; Bradycardia; Carbamazepine; Disseminated I

1999